TD Securities (USA)’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$18K Buy
177
+1
+0.6% +$103 0.16% 53
2015
Q4
$21K Sell
176
-276
-61% -$31.9K 0.19% 47
2015
Q3
$49K Sell
452
-320,768
-100% -$39.8M 0.45% 47
2015
Q2
$37.2M Buy
321,220
+33,617
+12% +$3.84M 0.5% 46
2015
Q1
$33.2M Sell
287,603
-15,692
-5% -$1.88M 0.5% 49
2014
Q4
$33.9M Buy
303,295
+23,635
+8% +$2.49M 0.49% 45
2014
Q3
$26.5M Sell
279,660
-296
-0.1% -$26.7K 0.43% 50
2014
Q2
$24M Buy
279,956
+13,476
+5% +$1.02M 0.39% 56
2014
Q1
$18.6M Sell
266,480
-24,286
-8% -$1.92M 0.33% 73
2013
Q4
$24.6M Buy
290,766
+9,136
+3% +$723K 0.41% 55
2013
Q3
$21.7M Sell
281,630
-2,824
-1% -$198K 0.41% 58
2013
Q2
$16.6M Buy
+284,454
New +$17.1M 0.33% 72

Other funds holding CELG

TD Securities (USA)'s CELG Position: Q1 2016 in Review

TD Securities (USA) increased its Celgene Corp (CELG) stake by 0.57% in Q1 2016, buying an estimated $103 and bringing the position to 177 shares worth $18K. The position accounts for 0.16% of the portfolio, ranked #53.

TD Securities (USA) first reported a position in CELG in Q2 2013 and has held it in 12 quarters since. The position peaked at $37.2M in Q2 2015. 1,224 funds tracked by Wall St. Rank hold CELG as of Q1 2016.

  • TD Securities (USA) held 177 shares of Celgene Corp worth $18K as of Q1 2016.
  • TD Securities (USA) bought 1 Celgene Corp share in Q1 2016, an estimated $103.
  • Celgene Corp made up 0.16% of TD Securities (USA)'s portfolio in Q1 2016, its #53 holding.
  • TD Securities (USA) first reported a position in Celgene Corp in Q2 2013 and has held it in 12 quarters since.
  • TD Securities (USA)'s Celgene Corp position peaked at $37.2M in Q2 2015.
  • 1,224 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2016.

Based on TD Securities (USA)'s 13F filing for Q1 2016, filed 27 Apr 2016.